4-(2-fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine
|
- $436 - $1414
- Product name: 4-(2-fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine
- CAS: 1263215-43-5
- MF: C14H10FN3O
- MW: 255.25
- EINECS:
- MDL Number:MFCD18324891
- Synonyms:4-(2-fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine;4-(2-Fluoro-phenyl)-6-furan-2-yl-pyrimidin-2-ylamine;2-Pyrimidinamine, 4-(2-fluorophenyl)-6-(2-furanyl)-
4 prices
Selected condition：
Brand
- Chemenu
- Crysdot
Package
- 1g
- 5g
- 10g
- ManufacturerChemenu
- Product numberCM337123
- Product description4-(2-Fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine 95%+
- Packaging1g
- Price$677
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11304246
- Product description4-(2-Fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine 97%
- Packaging10g
- Price$1414
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11304246
- Product description4-(2-Fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine 97%
- Packaging5g
- Price$1107
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11304246
- Product description4-(2-Fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine 97%
- Packaging1g
- Price$436
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Chemenu | CM337123 | 4-(2-Fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine 95%+ | 1g | $677 | 2021-12-16 | Buy |
| Crysdot | CD11304246 | 4-(2-Fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine 97% | 10g | $1414 | 2021-12-16 | Buy |
| Crysdot | CD11304246 | 4-(2-Fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine 97% | 5g | $1107 | 2021-12-16 | Buy |
| Crysdot | CD11304246 | 4-(2-Fluorophenyl)-6-(furan-2-yl)pyrimidin-2-amine 97% | 1g | $436 | 2021-12-16 | Buy |
Properties
Boiling point :466.4±55.0 °C(Predicted)
Density :1.304±0.06 g/cm3(Predicted)
pka :2?+-.0.10(Predicted)
Density :1.304±0.06 g/cm3(Predicted)
pka :2?+-.0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|